E-DRUG Archives (by thread)

  • [e-drug] RFI counterfeit drugs (cont), MURTADA SESAY
  • [e-drug] Vitamin A and child deaths in India (cont), Kirsten Myhr
  • [e-drug] Advertising in online journals (cont), Staffan Svensson
  • [e-drug] Adverse effects of mefloquine: due to primary liver damage?, andrew Herxheimer
  • [e-drug] Brain-drain of health professionals, Avisha Neerahoo
  • [e-drug] DTC advertising, Bella Brushin
  • [e-drug] Pakistan: Sales Tax on Medicines (cont), Azhar Hussain
  • [e-drug] Brain-drain of health professionals (cont), MURTADA SESAY
  • [e-drug] Advertising and marketing of essential drugs, Belinda Assam
  • [e-drug] Supply crisis of BMS ARVs in Kenya, daniel_berman
  • [e-drug] BMJ Ed: Murder by fake drugs, Kirsten Myhr
  • [e-drug] HIV drug under review, E-drug
  • [e-drug] Global Fund overwhelmed by requests, E-drug
  • [e-drug] Thalidomide supplie, Leona Coetzer PPC
  • [e-drug] Seminar on the Ethics of Research related to Healthcare in Developing Countries, Yvonne Melia
  • [e-drug] Re: DTC advertising, Barbara Mintzes
  • [e-drug] 2001 International Drug Price Indicator Guide, Julie McFadyen
  • [e-drug] Re: Thalidomide supplier, Kirsten Myhr
  • [e-drug] Re: Advertising and marketing of essential drugs, Kibumba George
  • [e-drug] Standardized Pill Imprint Codes USP, Gordon Schiff
  • [e-drug] Essential drugs model list by ATC, Kirsten Myhr
  • [e-drug] Re: Supply crisis of BMS ARVs in Kenya, Mary Ojoo
  • [e-drug] Just how tainted has medicine become?, Kirsten Myhr
  • [e-drug] Re: Just how tainted has medicine become?, Tom Poe
  • [e-drug] Re: Standardized Pill Imprint Codes USP, Bernhard Edgren
  • [e-drug] Annual Conference Pharmaceutical Society of Kenya, Mary Ojoo
  • [e-drug] WHO EDL Committee to consider 6 more antiretrovirals, WilbertBannenberg
  • [e-drug] New HAI Europe report on advertising medicines, Lisa Hayes
  • [e-drug] Re: WHO EDL Committee to consider 6 more antiretrovirals, James Love
  • [e-drug] Double or dubious standards for regulation and export?, Kirsten Myhr
  • [e-drug] description/definition of essential drugs by WHO, WilbertBannenberg
  • [e-drug] updating WHO EDL/EML, WilbertBannenberg
  • [e-drug] WHO model formulary, WilbertBannenberg
  • [e-drug] Essential drug or essential medicine?, B . Futter
  • [e-drug] Re: Essential drug or essential medicine?, Alistair Bolt
  • [e-drug] What drugs could be removed from WHO Model EDL?, Richard Laing
  • [e-drug] Re: description/definition of essential drugs by WHO, Patrice Trouiller
  • [e-drug] Botswana president backs ARV roll-out, e-drug
  • [e-drug] Re: description/definition of essential drugs, Murtada Sesay
  • [e-drug] Study on tax subsidies for donations of expiring drugs, Kirsten Myhr
  • [e-drug] Generic drug pricing fraud in the UK?, Jon Harper
  • [e-drug] Re: Study on tax subsidies for donations of expiring drugs, Bonnie Fundafunda
  • [e-drug] Attendance to Open Session EDL WHO meeting, Carmen Perez
  • [e-drug] Contents of Prescrire International April 2002, Prescrire International
  • [e-drug] Re: Proposed Donation Legislation in the UK, S. Hillstrom
  • [e-drug] Tightness of drug regulation in the North, Khalil Elouardighi
  • [e-drug] Recruitment of patients for drug trials, Cheri Grace
  • [e-drug] Australian Prescriber April 2002, Susan Reid
  • [e-drug] Re: Double or dubious standards for regulation and export?, Kirsten Myhr
  • [e-drug] More information on DTCA, Lisa Hayes
  • [e-drug] Re: What drugs could be removed from WHO Model EDL?, Ayesha Ahmed
  • [e-drug] TheNetwork's Campaign Against GST on medicines, Azhar Hussain
  • [e-drug] Brain drain of health professionals (cont'd), Susan Foster
  • [e-drug] Article in Milwaukee Journal Sentinel, Cathy Crawford
  • [e-drug] MSF letter Lancet: Generic medicines are not substandard, Ingrid Cox
  • [e-drug] Involve key players at implementation stage, Kibumba George
  • [e-drug] Re: TheNetwork's Campaign Against GST on medicines, Warren Kaplan
  • [e-drug] Independence of pharmacy inspection, Duangtip
  • [e-drug] Re: Independence of pharmacy inspection, Jon Harper
  • [e-drug] European socialist on TRIPs and Public Health, Seco Gerard
  • [e-drug] ARV-treatment in developing countries?, Stine Nielsen
  • [e-drug] Vitamin A and child deaths in India, Uzodinma Adirieje
  • [e-drug] Free Online Access to Academic Journals, Sharron Lawrence
  • [e-drug] New guidelines available, Enid Meldrum
  • [e-drug] SEAM Program country initiatives, Keith Johnson
  • [e-drug] MSF Letter to Global Fund Board and TRP, Rachel Cohen
  • [e-drug] Oxfam on international trade rules, E-drug
  • [e-drug] Re: MSF letters Lancet, Generic medicines & Global Fund, Kibumba George
  • [e-drug] NEJM -- Ross et al. 346(16):1212, 2002., Valeria Frighi
  • [e-drug] Help - drug regulation, Khalil Elouardighi
  • [e-drug] SA U turn on AIDS Policy!!, Ellen 't Hoen
  • [e-drug] HGAP/MSF/NGO Global Fund Press Call, Asia . Russell ,
  • [e-drug] WHO Press Release on ARVs and the Essential Drugs List, E-drug
  • [e-drug] WHO new EDL to contain 10 ARVs, WilbertBannenberg
  • [e-drug] Safe disposal of expired drugs, Jan Komrska
  • [e-drug] new WHO ART guidelines, Vareldzisb
  • [e-drug] detailed communication re new WHO EDL, andy
  • [e-drug] Deregulation of the pharmaceutical sector in Pakistan, Azhar Hussain
  • [e-drug] ISDB on EU consultation on child medicines, Christophe Kopp
  • [e-drug] Re: Safe disposal of expired drugs, Robin Gray
  • [e-drug] New WHO ARV guidelines, Jos Perriens
  • [e-drug] US Congress certain to approve major GFATM boost, Paul Davis
  • [e-drug] Re: ISDB on EU consultation on child medicines, Mary Ojoo
  • [e-drug] Global Fund commits USD 616m, e-drug
  • [e-drug] Internet sales threaten drug companies' supremacy, E-drug
  • [e-drug] Medicines in Europe Forum, Christophe Kopp
  • [e-drug] Ethics of research on healthcare in developing countries, Yvonne Melia
  • [e-drug] WHO on artemisine combination therapy, WilbertBannenberg
  • [e-drug] Global Fund: Activists demand focus on AIDS treatment, Olivier Jablonski
  • [e-drug] Re: Amodiaquine, Richard Laing
  • [e-drug] Meeting Report TA, Doha, TRIPS and Health, Mai DO
  • [e-drug] Designing medicines information and labels, WilbertBannenberg
  • [e-drug] Re: WHO on artemisine combination therapy, Mary Ojoo
  • [e-drug] Uganda MOH website, Peggy D'Adamo
  • [e-drug] Re: Essential antimalarials for paediatric use, FH Jansen
  • [e-drug] Re: Toxicity amodiaquine vs ARVs, Kibumba George
  • [e-drug] Global funding for malaria. How much for Africa?, FH Jansen
  • [e-drug] Re: Internet sales threaten drug companies' supremacy, Eduardo Satué
  • [e-drug] Announcing the new E-Drug website, E-drug
  • [e-drug] Re: Uganda MOH website, Bonnie Fundafunda
    • Mail converted by MHonArc 2.6.8